Runx1 transcription factor modulates opioid analgesia and withdrawal in humans and rodents

Key Points

• Runx1 transcription factor modulation influences opioid analgesia and withdrawal response, affecting pain management strategies.
• Key evidence highlights the effect of Runx1 in both human and rodent models, revealing variability in analgesic efficacy.
• Observational analysis across both species emphasizes the genetic modulation of neurotransmission pathways influenced by Runx1.
• Understanding Runx1's role in opioid response may enable targeted interventions, especially in withdrawal management.